Scorpius Inc. (SCPX)
AMEX: SCPX
· Real-Time Price · USD
0.04
-0.01 (-12.47%)
At close: May 01, 2025, 2:15 PM
0.04
0.00%
After-hours: May 01, 2025, 02:15 PM EDT
Company Description
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization.
The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies.
It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays.
The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024.
Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
Scorpius Inc.

Country | United States |
IPO Date | Jul 24, 2013 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 82 |
CEO | Jeffrey Alan Wolf J.D. |
Contact Details
Address: 627 Davis Drive Morrisville, North Carolina United States | |
Website | https://www.scorpiusbiologics.com |
Stock Details
Ticker Symbol | SCPX |
Exchange | AMEX |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001476963 |
CUSIP Number | n/a |
ISIN Number | US42237K4094 |
Employer ID | 26-2844103 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Jeffrey Alan Wolf J.D. | Founder, Chairman, President & Chief Executive Officer |
Joe Payne | President & Chief Operating Officer of Scorpius BioManufacturing |
William L. Ostrander | Chief Financial Officer, Controller & Secretary |
Colonel George E. Peoples Jr., F.A.C.S., M.D. | Chief Medical Advisor |
Dr. Justin Stebbing FRCP, FRCPath, M.A., M.D., Ph.D. | Chief Medical Advisor and Member of Scientific & Clinical Advisory Board |
Nicole Temple | Senior Manager & Head of Program Management |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 30, 2025 | 10-K | Annual Report |
Apr 28, 2025 | RW | Filing |
Apr 21, 2025 | 8-K | Current Report |
Apr 01, 2025 | NT 10-K | Filing |
Mar 28, 2025 | 8-K | Current Report |
Mar 20, 2025 | 8-K | Current Report |
Mar 13, 2025 | 8-K | Current Report |
Mar 12, 2025 | 3 | Filing |
Mar 04, 2025 | 8-K | Current Report |
Feb 27, 2025 | 8-K | Current Report |